CN1112438A - Chinese medicine compound hematic tonic liniment and its preparing method - Google Patents

Chinese medicine compound hematic tonic liniment and its preparing method Download PDF

Info

Publication number
CN1112438A
CN1112438A CN 95103710 CN95103710A CN1112438A CN 1112438 A CN1112438 A CN 1112438A CN 95103710 CN95103710 CN 95103710 CN 95103710 A CN95103710 A CN 95103710A CN 1112438 A CN1112438 A CN 1112438A
Authority
CN
China
Prior art keywords
chinese medicine
liniment
hematic
tonic
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95103710
Other languages
Chinese (zh)
Inventor
胡英姿
曾永保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95103710 priority Critical patent/CN1112438A/en
Publication of CN1112438A publication Critical patent/CN1112438A/en
Pending legal-status Critical Current

Links

Abstract

The medicinal liquid for external use is prepared from a small amount of arsenide and Chinese angelica, stem of spatholobus, codonopsis pilosula, root of astragalus membranaceus, pseudo-ginseng, soap vitriol, blue vitriol, antioxidizing agent, preservative and skin osmosis promoter, and is spread on the skin and capable of preventing and treating anemia and diseases caused by deficiency of the vital energy and the blood.

Description

Chinese medicine compound hematic tonic liniment and its preparing method
The present invention relates to a kind of prevention and treatment human body or the Chinese medicine preparation of diseases such as mammal anemia, deficiency of both QI and blood and production method of this preparation that absorbs through skin.
Anemia is the commonly encountered diseases of human body and animal, and its symptom is weak, and resistance is poor, if infant or children mammal in age, health was poor when getting anemia, hypoevolutism, mental retardation, very easy other disease that causes, treat this disease and mainly be at present the injection of oral medicine and injection, and inject pretty troublesomely, oral medicine is to some people curative effect and not obvious, particularly some child is reluctant to take medicine and have an injection.For children mammal in age, because the foodstuff beyond the breast milk of still can oneself not looking for food generally also is difficult to irritate feed.Relevant by retrieval data and document also can not made in vigorous health dose open report again about utilizing the Chinese medicine compound liniment to do prevention and treatment human body or animal anemia agent medicine at present.
The purpose of this invention is to provide and a kind ofly utilize some Chinese medicine, mineral and other to promote additive combination after be coated with and put the medicinal liquid that just can reach prophylactic treatment anemia and the said deficiency of both QI and blood of theory of Chinese medical science on human body or mammal skin surface on the skin.
Medicinal liquid of the present invention mainly comprises a spot of arsenic compound, have the synthesis material copper sulfate of some Chinese medicine of blood yiqi effect, hemoglobin and ferrous sulfate and antioxidant, the material of complexing of metal ion agent, anticorrosion system, surfactant, also should add dermal osmosis accelerator, cooperatively interact by these materials, it is reached is easily absorbed by skin surface, stimulate the effect of human body or mammal hematopoietic function, strengthening body, below introduce composition, content and the compound method of medicinal liquid respectively:
One, arsenic compound
The present invention is chosen at the arsenic compound of Chinese medicine safe level as main liquid (I), and the material of being got can be chosen any one kind of them in following compounds: (1) arsenic sulfide AsS, (2) arsenic trioxide As 2O 3, (3) arsenite (KAsO, NaAsO), (4) atoxylic acid (arsanilic acid) and salt thereof, (5) contain the chemical compound (as ferric methylarsonate, sodium methylarsonate, sodium dimethyl arsine etc.) of methanearsonic acid.
Above-mentioned inorganic arsenic needs it is dissolved in small amounts of sodium hydroxide or the potassium hydroxide solution before use, and organo-arsenic is dissolved in polar organic solvent such as dimethyl sulfoxide, N, and dinethylformamide etc. add a small amount of distilled water diluting again, and are standby.Its concentration is the 0.01-2% of total dose, the weight (gram) in promptly per 100 milliliters of total medicinal liquids, and preferred concentration 0.3-0.5%, this solution are main liquid (I).
Two, Chinese medicine part (pressing the title of Chinese medicine handbook):
(1) optional 1-3 kind or whole in Radix Angelicae Sinensis, Caulis Spatholobi, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Radix Paeoniae Alba.
(2) optional 1-3 kind or all in the middle of Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Fructus Jujubae, Radix Notoginseng, Radix Glycyrrhizae, its content contains crude drug weight and accounts for medicinal liquid gross weight (100 milliliters) to amount to, and every kind of Chinese medicine that is selected into is generally 10-80%.
Above-mentioned Chinese medicine generally need extract its active ingredient with separating out alcohol method, decocting method or the way of distillation, and is standby, and this solution is main liquid (II).
Three, Melanteritum and Chalcanthitum, Melanteritum are FeSO 47H 2O, Chalcanthitum are CuSO 45H 2O, the use amount of Melanteritum is the 20-45% of total amount of liquid medicine, (the total amount of liquid medicine of g/100ml), the optimum consumption is 30-40%, the consumption of Chalcanthitum is 2-20%, and the optimum consumption is 5-10%, and Melanteritum and Chalcanthitum add the mode of medicinal liquid for being dissolved in an amount of distilled water, filter the back and merge with the main liquid that above-mentioned Chinese medicine makes, standby.
Four, antioxidant, complexing of metal ion agent, antiseptic, surfactant, selected antioxidant is ascorbic acid or thiourea, sodium pyrosulfite, sodium sulfite etc., it is with being 0.05-4%, disodiumedetate is selected in the complexing of metal ion agent for use, its consumption is 0.01-0.5%, and it is 0.01-0.5% that antiseptic adopts its consumptions such as Nipagin ester, sodium benzoate, and surfactant adopts Tweens, consumption is 0.01-0.5%, is added in the medicinal liquid behind all available dissolved in distilled water of these additives.
Five, dermal osmosis accelerator is selected for use in following material: azone 1-3%, propylene glycol 10-15%, nicotinate 1-2%, salicylic acid 3-4%, and ethyl acetate 5-10%, ethyl lactate 5-10%, dissolved in distilled water is used in also optional wherein two kinds of combinations.
Above-mentioned third and fourth, each compositions of 5 and medicinal liquid (I) and medicinal liquid (II) all mix after preparing, adding distil water is regulated pH value again, reach 100ml, promptly obtain Chinese medicine compound of the present invention and enrich blood and put on the skin, the liniment pH value that is made into is 4.0-7.0, and best PH is 5.0-6.0.
Liniment of the present invention belongs to a kind of exterior-applied formulation, can not be oral or make injection, during use medicinal liquid is coated on the surface skin around child's umbilicus or on the nascent mammiferous basal part of the ear skin of back, for iron Deficiency Anemia and weak, the patient who belongs to deficiency of both QI and blood is evident in efficacy, and is excellent for clinical application effects such as nascent mammal such as piglets, doggie, lambs.
The prevention of liniment of the present invention and treatment anemia mechanism are to embrocate medication by local skin, transdermal penetration absorbs and enters blood circulation, and the whole body pharmacological action takes place, and it and drug administration by injection have some similarity, can be blood absorption, institute's difference is that repeated transmission was delivered to blood, in general after the present invention passed through skin absorbs earlier, though Transdermal absorption is slow, repeatedly medication is not subjected to syringe needle to thrust suffering of flesh but evenly.
The Main Ingredients and Appearance arsenic of liniment of the present invention is a kind of poisonous chemical element, belong to cellular plasm slurry poisonous substance matter, but an amount of scope external that is limiting, significant stimulation bone marrow hematogenesis function is arranged, play strong blood tonification effect, removing toxic substances is sharp, some Saponins in some materials in the Chinese medicinal ingredients such as the milletol in the Caulis Spatholobi, the Radix Angelicae Sinensis oil in the Radix Angelicae Sinensis, Radix Codonopsis, Radix Notoginseng, the Radix Astragali, very easily transdermal penetration is that body absorbs and the strong effect of directly enriching blood under the skin penetrant effect, and is identical with herbal function for oral administration; Fe in Melanteritum and the Chalcanthitum 2+, Cn 2+Be the synthesis material of hemoglobin, work as Fe 2+During shortage, the human or animal very easily suffers from iron deficiency anemia, Cu 2+Coordination is arranged, promote Fe 2+Absorption, utilization effect, above-mentioned each active ingredient is mended mutually and is coordinated, and uses properly, can enhance metabolism human body immunity improving function, and play the effect of the strengthening body of enriching blood.
The present invention has the following advantages:
One, excavates and enriched chinese tradition medicine culture, filled up the blank of Chinese medicine on Transdermal absorption dosage form aspect enriching blood.
Two, easy to use, need not have an injection and take medicine, only need be coated with and put the same effect that on specific acupuncture point, can play and have an injection and take medicine on the skin with medicinal liquid, use for child or animal, more convenient.
Three, prescription is more flexible, owing to added arsenic compound, Fe 2+, Cu 2+And the combination of composition such as Chinese medicine, have integrate enrich blood, QI invigorating and strong etc. multi-functional, function is extensive.
Below be embodiments of the invention:
Embodiment one, 1 kilogram of Radix Angelicae Sinensis crude drug is added the method for an amount of distilled water by the water cooking liquid of distillation post processing earlier, collect Radix Angelicae Sinensis oil and water cooking liquid, again 0.8 kilogram of Radix Codonopsis is added an amount of distilled water and decoct, collect decocting liquid, merge above-mentioned two kinds of solution, add ethanol and make that to contain amount of alcohol be about 70%, low temperature is placed more than 8 hours and is filtered, obtain medicinal liquid (II), to take by weighing sodium arsenite or arsenic sulfide 80 grams again and add the dissolving of 10%NaOH solution, medicinal liquid (I), other gets FeSO 47H 2The O600 gram, CuSO 45H 2O100 gram disodiumedetate 10 grams, sodium pyrosulfite 20 grams, Tween 80,800 milliliters, be dissolved in a small amount of distilled water, merge, add azone 400ml with medicinal liquid (I) and medicinal liquid (II), antiseptic is an amount of, add water, regulating PH with HCl or NaOH is 5.8-6.5, and complementing to total liquid measure is 20,000 milliliters, filter, packing gets final product.
Embodiment two, and Caulis Spatholobi, Radix Angelicae Sinensis, Radix Polygoni Multiflori, the Radix Astragali, each 2kg of the Rhizoma Atractylodis Macrocephalae mix and pulverize, flood 3 times repeatedly to there not being the medicine color with 65-70% ethanol, concentrate the Chinese medicine transudate, reclaim ethanol, medicinal residues add an amount of distilled water and decoct, and filter, and filtrate recycling ethanol and leaching concentrated medicament are standby; Accurately take by weighing AS 2O 315 grams, Caustic soda 120 grams add an amount of distilled water and are stirred to dissolving after the mixing, transfer PH near neutral with rare HCl, and standby, other gets an amount of dissolved in distilled water ascorbic acid 100g, EDTA80 gram, Tween 80,100ml, sodium benzoate 40 grams, FeSO 47H 2The O800 gram, CuSO 45H 2The O100 gram mixes above-mentioned various solution, adds azone 300ml, and ethyl acetate 500ml transfers PH to 6.5-7.0 with HCl and NaOH, and supplying distilled water to total amount is 30,000 milliliters, filters, and packing gets final product.
Embodiment three, change Chinese medicine into Radix Rehmanniae Preparata and Radix Notoginseng, and each 2 kilograms, extract medicinal liquid with decocting method, produce 20,000 milliliters of liniments by the method for embodiment one.
Embodiment four, change Chinese medicine into Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Fructus Jujubae respectively 1.5 kilograms, extract medicinal liquid with separating out alcohol method, and arsenic compound changes sodium methanearsonate 20 grams into, uses dmso solution, and all the other methods are pressed embodiment two, make 30,000 milliliters of liniments.
Use embodiment one,
Product of the present invention uses newborn piglet 1-2 age in days on pig farm, Guilin city, every is coated with and puts skin of back 1-2ml on the skin, only be coated with once, nonuser every of average specific increases weight productive rate more than 30% after 10 days, the no any discomfort in back of applying ointment, have no side effect, the 3rd day skin begins delicate glow under the normal condition, and animal is active, physically well develops, and with matched group relatively, piglet is difficult for taking place diseases such as Huang, Bai Ji.
Use embodiment two,
Product of the present invention in county township, Lipu, Guilin City to 4 years old Lee child * * use, originally Lee * * the thin Huang of face, appetite is few, verifies as iron deficiency anemia through blood drawing, after be coated with this product 3 times, is 2-3ml at every turn, face begins ruddyly after January, appetite is normal.

Claims (6)

1, a kind of Chinese medicine compound hematic tonic liniment contains FeSO 4And skin penetrant, it is characterized in that the composition of this liniment is:
(1) arsenic compound at arsenic sulfide, arsenic trioxide, potassium arsenite, sodium arsenite, p-aminophenyl arsine and salt thereof, ferric methylarsonate, is chosen any one kind of them in sodium methylarsonate, the swollen sour sodium of dimethyl;
(2) Chinese medicine, optional 1-3 kind or whole in Radix Angelicae Sinensis, Caulis Spatholobi, Radix Rehmanniae Preparata, Radix Polygoni Multiflori, the Radix Paeoniae Alba; Optional 1-3 kind or whole in the middle of Radix Codonopsis, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Fructus Jujubae, Radix Notoginseng, Radix Glycyrrhizae.
(3) Melanteritum and Chalcanthitum;
(4) antioxidant, metal ion complex, antiseptic, surfactant and dermal osmosis accelerator.
2, Chinese medicine compound hematic tonic liniment according to claim 1, the content that it is characterized in that arsenic compound is the 0.01-2% of total dose, preferred 0.3-0.5%.
3, Chinese medicine compound hematic tonic liniment according to claim 1, the content that it is characterized in that Chinese medicine is the 10-80% of total dose.
4, Chinese medicine compound hematic tonic liniment according to claim 1, the content that it is characterized in that Melanteritum is 20-45%, optimum content is 30-40%; The consumption of Chalcanthitum is 2-20%, and the optimum consumption is 5-10%.
5, Chinese medicine compound hematic tonic liniment according to claim 1 is characterized in that antioxidant is ascorbic acid or thiourea, sodium pyrosulfite, sodium sulfite, and its content is 0.05-4%; Metal ion complex is a disodiumedetate, and its content is 0.01-0.5%; Antiseptic Nipagin ester, sodium benzoate, its content is 0.01-0.5%; Surfactant is a Tweens, and its content is 0.01-0.5%, and dermal osmosis accelerator is azone or propylene glycol, nicotinate, salicylic acid, ethyl acetate or ethyl lactate, and its content is respectively 1-3%, 10-15%, 1-2%, 3-4%, 5-10%, 5-10%.
6, a kind of production method of Chinese medicine compound hematic tonic liniment as claimed in claim 1, it is characterized in that earlier inorganic arsenic chemicals being dissolved in sodium hydroxide or the potassium hydroxide solution, organic arsine is dissolved in polar organic solvent such as dimethyl methyl inkstone, N, in the dinethylformamide, the amount of water distilled water diluting gets main liquid (I); Use separating out alcohol method after getting required Chinese medicine weighing, the decocting method or the way of distillation are extracted its active ingredient, get main liquid (II), then by measuring antioxidant, complexing of metal ion agent, antiseptic, surfactant, dermal osmosis accelerator, use dissolved in distilled water respectively, again and main liquid (I) and (II) merge, regulate PH, adding distil water to 100% promptly obtains compound hematic tonic liniment.
CN 95103710 1995-04-12 1995-04-12 Chinese medicine compound hematic tonic liniment and its preparing method Pending CN1112438A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95103710 CN1112438A (en) 1995-04-12 1995-04-12 Chinese medicine compound hematic tonic liniment and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95103710 CN1112438A (en) 1995-04-12 1995-04-12 Chinese medicine compound hematic tonic liniment and its preparing method

Publications (1)

Publication Number Publication Date
CN1112438A true CN1112438A (en) 1995-11-29

Family

ID=5074813

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95103710 Pending CN1112438A (en) 1995-04-12 1995-04-12 Chinese medicine compound hematic tonic liniment and its preparing method

Country Status (1)

Country Link
CN (1) CN1112438A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101401820B (en) * 2008-10-14 2011-03-23 张南 Injection novel medicine for treating systematic lupus erythematosus
US8110215B2 (en) 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110215B2 (en) 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
CN101401820B (en) * 2008-10-14 2011-03-23 张南 Injection novel medicine for treating systematic lupus erythematosus

Similar Documents

Publication Publication Date Title
CN102614102B (en) Dandruff-removing medicinal composition and preparation method thereof
CN103301408B (en) Traditional Chinese medicine extract and massage cream prepared from extract
CN103251741B (en) Chinese medicine composition for treating toxoplasmosisinswine, and preparation method and application thereof
CN102274252B (en) Stauntonvine external applied preparation for treating rheumatoid diseases and preparation method thereof
CN106039022B (en) Skin-brightening and whitening traditional Chinese medicine composition, skin-brightening and whitening traditional Chinese medicine preparation, skin-brightening and whitening mask and preparation method
CN101007085B (en) A drug for treating hyperthyroidism and its preparation method
CN111558031A (en) Pure plant multifunctional eye special nutrient solution and preparation method thereof
CN1259900C (en) Body-building disease-removing bath foam
CN105561285A (en) Ground beeltle biological activity small peptide composition
CN1112438A (en) Chinese medicine compound hematic tonic liniment and its preparing method
CN1055850C (en) Medicated wine for expelling wind
CN102988781A (en) Traditional Chinese medicine liniment for inhibiting cancer and relieving pain
CN112494502A (en) Saccharide composition for enriching blood of blood deficiency syndrome
CN102784230A (en) Pharmaceutical composition preparation for treating nutritional anemia
CN110934938A (en) A pharmaceutical composition for foot and its preparation method
CN111671871A (en) Chinese herbal medicine for treating joint diseases by Mongolian donkey bone sibutrol therapy
CN1045388C (en) Four-herb protein reducing soup for treatment of proteinuria caused by acute and chronic nephritis and producing method thereof
CN1171604C (en) Liquid method for growing hair
CN108126154A (en) A kind of preparation method and application for the nano dispersion fluid for treating obstruction of collaterals by blood stasis arthralgia-syndrome pain
CN108042777A (en) A kind of spring Traditional Chinese medicine health tea for benefiting qi and raising yang
CN1214928A (en) Pure natural biological nutrient liquid
CN101181440A (en) Chinese medicine composition for curing hemopathy as well as preparation method and usage thereof
CN1171242A (en) Compound anticancer Chinese medicine
CN102309572A (en) Blood nourishing oral liquid and preparation method thereof
CN1177592C (en) Myocarditis treating medicine

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication